Effect of insulin on blood rheology in non-diabetic subjects and in patients with Type 2 diabetes mellitus
- PMID: 9400920
- DOI: 10.1002/(SICI)1096-9136(199711)14:11<959::AID-DIA499>3.0.CO;2-U
Effect of insulin on blood rheology in non-diabetic subjects and in patients with Type 2 diabetes mellitus
Abstract
We evaluated the effect of insulin on platelet function, blood viscosity, and filterability in healthy subjects and in patients with Type 2 (non-insulin-dependent) diabetes mellitus. Fifteen diabetic patients were free from cardiovascular complications (group A), while the other 15 patients had both clinical and measured evidence of coronary or peripheral vascular disease (group B); 15 non-diabetic subjects served as controls. On blood samples taken without stasis, maximal platelet aggregation to 1.25 micromol l(-1) ADP, blood and plasma viscosity, and blood filterability were measured in basal conditions, and after incubation of blood, plasma or platelet-rich plasma with insulin at two physiological concentrations (120 and 480 pmol l(-1)). Compared with healthy subjects, the diabetic patients of group B had higher values of blood (p < 0.01) and plasma (p < 0.05) viscosity, and platelet aggregation response to ADP (p < 0.01), as well as lower values of blood filterability (p < 0.01). The diabetic patients of group A had values intermediate between normal subjects and the patients of group B. In non-diabetic subjects, insulin significantly decreased platelet aggregation and blood viscosity at low shear rates (22.5 s(-1)) (p < 0.01 for both), and had no significant effects on other parameters. In the diabetic patients of group A, insulin decreased blood viscosity at high (225 s(-1)) rates of shear (p < 0.01) and increased blood filterability (p < 0.01). The effects of insulin were not dose-related. In the diabetic patients of group B, none of the parameters evaluated was significantly influenced by insulin. Type 2 diabetic patients present many abnormalities of the rheologic properties of blood. The beneficial effects of insulin on platelet aggregation and blood viscosity are not evident in Type 2 diabetic patients, especially those with vascular complications and this may be relevant to the development of those complications.
Similar articles
-
Metformin improves hemodynamic and rheological responses to L-arginine in NIDDM patients.Diabetes Care. 1996 Sep;19(9):934-9. doi: 10.2337/diacare.19.9.934. Diabetes Care. 1996. PMID: 8875085 Clinical Trial.
-
Effects of low-dose EPA-E on glycemic control, lipid profile, lipoprotein(a), platelet aggregation, viscosity, and platelet and vessel wall interaction in NIDDM.Diabetes Care. 1993 May;16(5):683-8. doi: 10.2337/diacare.16.5.683. Diabetes Care. 1993. PMID: 8495604 Clinical Trial.
-
Abnormal rheologic effects of glyceryl trinitrate in patients with non-insulin-dependent diabetes mellitus and reversal by antioxidants.Ann Intern Med. 1995 Sep 1;123(5):338-43. doi: 10.7326/0003-4819-123-5-199509010-00003. Ann Intern Med. 1995. PMID: 7625621
-
[Blood rheology abnormalities in diabetes mellitus].J Mal Vasc. 1989;14(1):64-7. J Mal Vasc. 1989. PMID: 2646390 Review. French.
-
Red cell deformability, platelet aggregation, and insulin action.Diabetes. 1983 May;32 Suppl 2:88-91. doi: 10.2337/diab.32.2.s88. Diabetes. 1983. PMID: 6400673 Review.
Cited by
-
Red blood cell membrane mechanical fluctuations in non-proliferative and proliferate diabetic retinopathy.Graefes Arch Clin Exp Ophthalmol. 2004 Nov;242(11):937-43. doi: 10.1007/s00417-004-0946-3. Epub 2004 Aug 4. Graefes Arch Clin Exp Ophthalmol. 2004. PMID: 15293056
-
Erythrocyte deformability and microhematuria in children and adolescents.Pediatr Nephrol. 2003 Feb;18(2):127-32. doi: 10.1007/s00467-002-1024-x. Epub 2003 Jan 17. Pediatr Nephrol. 2003. PMID: 12579401
MeSH terms
Substances
LinkOut - more resources
Medical